These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25573984)

  • 21. Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study.
    Huang WP; Zhang YH; He L; Su X; Yang XW; Guo ZX
    Chin Med J (Engl); 2017 Feb; 130(4):434-438. PubMed ID: 28218217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Kefer J; Tzikas A; Freixa X; Shakir S; Gafoor S; Nielsen-Kudsk JE; Berti S; Santoro G; Aminian A; Landmesser U; Nietlispach F; Ibrahim R; Danna PL; Benit E; Budts W; Stammen F; De Potter T; Tichelbäcker T; Gloekler S; Kanagaratnam P; Costa M; Cruz-Gonzalez I; Sievert H; Schillinger W; Park JW; Meier B; Omran H
    Int J Cardiol; 2016 Mar; 207():335-40. PubMed ID: 26820363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events.
    Teiger E; Thambo JB; Defaye P; Hermida JS; Abbey S; Klug D; Juliard JM; Pasquie JL; Rioufol G; Lepillier A; Elbaz M; Horvilleur J; Brenot P; Pierre B; Le Corvoisier P;
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005841. PubMed ID: 29540492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
    Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.
    Landmesser U; Holmes DR
    Eur Heart J; 2012 Mar; 33(6):698-704. PubMed ID: 22041550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation.
    Fassini G; Conti S; Moltrasio M; Maltagliati A; Tundo F; Riva S; Dello Russo A; Casella M; Majocchi B; Zucchetti M; Russo E; Marino V; Pepi M; Tondo C
    Europace; 2016 Nov; 18(11):1705-1710. PubMed ID: 27402623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications.
    Pillarisetti J; Reddy YM; Gunda S; Swarup V; Lee R; Rasekh A; Horton R; Massumi A; Cheng J; Bartus K; Badhwar N; Han F; Atkins D; Bommana S; Earnest M; Nath J; Ferrell R; Bormann S; Dawn B; Di Biase L; Mansour M; Natale A; Lakkireddy D
    Heart Rhythm; 2015 Jul; 12(7):1501-7. PubMed ID: 25778430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplatzer left atrial appendage occlusion: single center 10-year experience.
    Nietlispach F; Gloekler S; Krause R; Shakir S; Schmid M; Khattab AA; Wenaweser P; Windecker S; Meier B
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):283-9. PubMed ID: 23412815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry.
    Wintgens L; Romanov A; Phillips K; Ballesteros G; Swaans M; Folkeringa R; Garcia-Bolao I; Pokushalov E; Boersma L
    Europace; 2018 Nov; 20(11):1783-1789. PubMed ID: 29547906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of sex differences on outcomes in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure: A single-center experience.
    Zhao M; Post F; Muenzel M; Hou CR; Keil T; Yu J
    Int J Med Sci; 2021; 18(9):1990-1998. PubMed ID: 33850469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Percutaneous closure of the left atrial appendage: a new option for the prevention of thromboembolic stroke].
    Oto A; Aytemir K; Okutucu S; Kaya EB; Sahiner L; Sabanov C; Evranos B
    Turk Kardiyol Dern Ars; 2011 Dec; 39(8):668-74. PubMed ID: 22257805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study.
    Bergmann MW; Ince H; Kische S; Schmitz T; Meincke F; Schmidt B; Foley D; Betts TR; Grygier M; Protopopov AV; Stein KM; Boersma LVA
    EuroIntervention; 2018 Apr; 13(17):2003-2011. PubMed ID: 29313819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
    Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of left atrial appendage occlusion in high-risk patients.
    Masoud A; Bartoletti S; Fairbairn T; Khurana A; Velavan P; Morrison WL; Khalatbari A; Aggarwal S; Sharma N; Kirchhof P; Gupta D
    Heart; 2018 Apr; 104(7):594-599. PubMed ID: 29122931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.
    Ledwoch J; Franke J; Gonzaga M; Bertog S; Braut A; Hofmann I; Vaskelyte L; Gafoor S; Reddy V; Sievert H
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):787-94. PubMed ID: 26354821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE
    Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double device left atrial appendage closure.
    Guérios ÊE; Gloekler S; Schmid M; Khattab A; Nietlispach F; Meier B
    EuroIntervention; 2015 Aug; 11(4):470-6. PubMed ID: 25007782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.
    Xue X; Jiang L; Duenninger E; Muenzel M; Guan S; Fazakas A; Cheng F; Illnitzky J; Keil T; Yu J
    Heart Vessels; 2018 Sep; 33(9):1068-1075. PubMed ID: 29564543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
    Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
    Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.